Trial
NCT01345630
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1
Phase IIITERMINATEDSAFETYConfidence: HIGH
Sponsor
ViiV Healthcare
Collaborators
Pfizer
Condition
HIV-1
Intervention
Maraviroc
Why stopped
See termination reason in detailed description.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-01-14